Phase 3 trial reached primary endpoint and demonstrated a reduction in SARS-CoV-2 log viral load in COVID-19 patients by more than 94% within 24 hours of treatment, and by more than 99% in 48 hours
Glenmark to sell nasal spray to treat adult Covid-19 patients daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.
Indian pharma major Glenmark Pharmaceuticals Limited and Canadian pharmaceutical company SaNOtize Research & Development Corp, on Wednesday announced launch of nasal spray to treat adult Covid-19 patients.According to Glenmark, the nitric .
In a major development in the COVID-19 medicine field, Glenmark Pharmaceuticals on Wednesday launched its Nitric Oxide Nasal Spray under the brand name FabiSpray in India.
Glenmark to sell nasal spray to treat adult Covid-19 patients daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.